| Donna Marie Lufkin, LPN | |
|
2683 South Paddock Drive, Wasilla, AK 99654-8451 | |
| (907) 631-3560 | |
| Not Available |
| Full Name | Donna Marie Lufkin |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 2683 South Paddock Drive, Wasilla, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003188780 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN5145438 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donna Marie Lufkin, LPN 2683 South Paddock Drive, Wasilla, AK 99654-8451 Ph: (907) 631-3560 | Donna Marie Lufkin, LPN 2683 South Paddock Drive, Wasilla, AK 99654-8451 Ph: (907) 631-3560 |
News Archive
People who eat meat frequently, especially meat that is well done or cooked at high temperatures, may have a higher chance of developing bladder cancer, according to a large study at The University of Texas M. D. Anderson Cancer Center presented at the American Association for Cancer Research 101st Annual Meeting 2010. This risk appears to increase in people with certain genetic variants.
Women who understand the risk of over-detection and over-diagnosis associated with mammography screening have lower intentions to have a breast screening test, according to a new Lancet study.
Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced issuance of Japanese Patent Number: 4354633, titled, "Hypoxia regulated genes," on August 7, 2009.
Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced top-line results from a successful Phase 2b double-blind, randomized, placebo-controlled clinical trial of its lead topical pain candidate, ARC-4558, in adult patients with painful diabetic neuropathy (PDN). Arcion recently held an End of Phase 2 meeting with the United States Food and Drug Administration (FDA) and the ARC-4558 program is now poised to enter Phase 3 studies.
› Verified 7 days ago
Rosanna A Miller, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2521 E Mountain Village Dr, Wasilla, AK 99654 Phone: 602-248-8886 | |
Zina Bodunov, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4921 S Binnacle Ave, Wasilla, AK 99654 Phone: 907-980-2056 | |
Mareena Michelle Becerril-wild, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4219 S Pinnacle Peak Dr, Wasilla, AK 99623 Phone: 907-521-5543 | |
Vanessa Gittlein, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 301 S Begich Dr, Wasilla, AK 99654 Phone: 907-414-8995 | |
Anna Meisel, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 189 E Nelson Ave # 238, Wasilla, AK 99654 Phone: 314-332-3981 | |
Madison Morgan, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6101 N Little Rock Cir, Wasilla, AK 99654 Phone: 907-570-8470 |